| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
As the premier gathering of top entrepreneurs and investors took place on Monday in New Jersey, we thought it would be a good time to scroll through the latest leadership changes in the cannabis and psychedelics industries.
Cybin Inc. (NYSE:CYBN) (Cboe CA: CYBN) a clinical-stage biopharmaceutical company that develops new and innovative next-generation psychedelic-based treatment options, announced recently that Dr. Atul R. Mahableshwarkar M.D., DLFAPA, opted to join the company as senior vice president of clinical development.
Dr. Mahableshwarkar agreed to lead the development of the CYB003 program, Cybin's proprietary deuterated psilocybin analog which has received U.S. Food and Drug Administration (FDA) Breakthrough Therapy Designation for the adjunctive treatment of major depressive disorder.
The annual general meeting of shareholders of Curaleaf Holdings, Inc. (TSX:CURA) (OTCQX:CURLF) was held on Friday, during which the following experts were elected as directors:
Cannabis powerhouse Planet 13 Holdings Inc. (CSE:PLTH) (OTCQX:PLNH) named David Loop, the former CEO of VidaCann LLC who has spent his entire career in the horticulture industry, to its board of directors, last week. The Las Vegas company acquired VidaCann May for $63.4 million. The new addition comes on the heels of its shareholders electing five experts to serve on its board.
Charlotte’s Web Holdings, Inc. (TSX:CWEB) (OTCQX:CWBHF) announced the results from its 2024 annual general and special meeting of shareholders held on June 13, during which the following nominees were elected to serve on the company's board of directors:
California cannabis company Flora Corporation's (Cboe Canada: GRAM) shareholders elected the following experts to its board of directors:
Canadian producer and distributor of cannabis products Entourage Health Corp. (TSXV:ENTG) (OTCQX:ETRGF) (FSE: 4WE) announced that shareholders overwhelmingly approved all proposed resolutions at its annual general meeting of shareholders held last week, including electexting the following nominees to its board of directors:
TILT Holdings Inc. (NEO: TILT) (OTCQB:TLLTF), provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, also announces the results of the 2024 annual general meeting of its shareholders. The following nominees were elected to serve as the company's directors:
Posted In: CSE:PLTH CURLF CWBHF CWEB CYBN ETRGF GRAM PLNH TILT TLLTF TSX:CURA TSX:CWEB TSXV:ENTG
